Literature DB >> 26350282

Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.

Avishkar Tyagi1, Omid Yeganeh2, Yakir Levin2, Jonathan C Hooker2, Gavin C Hamilton2, Tanya Wolfson3, Anthony Gamst3, Amir K Zand2, Elhamy Heba2, Rohit Loomba4,5, Jeffrey Schwimmer2,6,7, Michael S Middleton2, Claude B Sirlin8.   

Abstract

PURPOSE: Determine intra- and inter-examination repeatability of magnitude-based magnetic resonance imaging (MRI-M), complex-based magnetic resonance imaging (MRI-C), and magnetic resonance spectroscopy (MRS) at 3T for estimating hepatic proton density fat fraction (PDFF), and using MRS as a reference, confirm MRI-M and MRI-C accuracy.
METHODS: Twenty-nine overweight and obese pediatric (n = 20) and adult (n = 9) subjects (23 male, 6 female) underwent three same-day 3T MR examinations. In each examination MRI-M, MRI-C, and single-voxel MRS were acquired three times. For each MRI acquisition, hepatic PDFF was estimated at the MRS voxel location. Intra- and inter-examination repeatability were assessed by computing standard deviations (SDs) and intra-class correlation coefficients (ICCs). Aggregate SD was computed for each method as the square root of the average of first repeat variances. MRI-M and MRI-C PDFF estimation accuracy was assessed using linear regression with MRS as a reference.
RESULTS: For MRI-M, MRI-C, and MRS acquisitions, respectively, mean intra-examination SDs were 0.25%, 0.42%, and 0.49%; mean intra-examination ICCs were 0.999, 0.997, and 0.995; mean inter-examination SDs were 0.42%, 0.45%, and 0.46%; and inter-examination ICCs were 0.995, 0.992, and 0.990. Aggregate SD for each method was <0.9%. Using MRS as a reference, regression slope, intercept, average bias, and R (2), respectively, for MRI-M were 0.99%, 1.73%, 1.61%, and 0.986, and for MRI-C were 0.96%, 0.43%, 0.40%, and 0.991.
CONCLUSION: MRI-M, MRI-C, and MRS showed high intra- and inter-examination hepatic PDFF estimation repeatability in overweight and obese subjects. Longitudinal hepatic PDFF change >1.8% (twice the maximum aggregate SD) may represent real change rather than measurement imprecision. Further research is needed to assess whether examinations performed on different days or with different MR technologists affect repeatability of MRS voxel placement and MRS-based PDFF measurements.

Entities:  

Keywords:  Complex-based MRI; Hepatic steatosis; Inter-examination repeatability; Intra-examination repeatability; Magnetic resonance spectroscopy; Magnitude-based MRI; Obesity; PDFF; Proton density fat fraction; Quantitative imaging biomarkers

Mesh:

Substances:

Year:  2015        PMID: 26350282      PMCID: PMC4819976          DOI: 10.1007/s00261-015-0542-5

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  29 in total

1.  Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals.

Authors:  A Naressi; C Couturier; I Castang; R de Beer; D Graveron-Demilly
Journal:  Comput Biol Med       Date:  2001-07       Impact factor: 4.589

2.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

3.  Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.

Authors:  Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

4.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

5.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

6.  Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method.

Authors:  D Hernando; C D G Hines; H Yu; S B Reeder
Journal:  Magn Reson Med       Date:  2011-06-28       Impact factor: 4.668

7.  Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.

Authors:  Giovanni Guaraldi; Giulia Besutti; Chiara Stentarelli; Stefano Zona; Luca Nocetti; Paola Loria; Stefano Ballestri; Luisa Losi; Pietro Torricelli; Guido Ligabue
Journal:  Antivir Ther       Date:  2012-07-05

8.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

9.  Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI.

Authors:  Benjamin L Johnson; Michael E Schroeder; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Masoud Shiehmorteza; Rohit Loomba; Jeffrey B Schwimmer; Scott Reeder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2013-04-17       Impact factor: 4.813

10.  Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Thuy-Anh Le; Joshua Chen; Christopher Changchien; Michael R Peterson; Yuko Kono; Heather Patton; Benjamin L Cohen; David Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

View more
  25 in total

1.  Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.

Authors:  Cyrielle Caussy; Meera Soni; Jeffrey Cui; Ricki Bettencourt; Nicholas Schork; Chi-Hua Chen; Mahdi Al Ikhwan; Shirin Bassirian; Sandra Cepin; Monica P Gonzalez; Michel Mendler; Yuko Kono; Irine Vodkin; Kristin Mekeel; Jeffrey Haldorson; Alan Hemming; Barbara Andrews; Joanie Salotti; Lisa Richards; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 2.  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ma Ai Thanda Han; Rola Saouaf; Walid Ayoub; Tsuyoshi Todo; Edward Mena; Mazen Noureddin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-03-09       Impact factor: 5.045

Review 3.  Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.

Authors:  Takeshi Yokoo; Suraj D Serai; Ali Pirasteh; Mustafa R Bashir; Gavin Hamilton; Diego Hernando; Houchun H Hu; Holger Hetterich; Jens-Peter Kühn; Guido M Kukuk; Rohit Loomba; Michael S Middleton; Nancy A Obuchowski; Ji Soo Song; An Tang; Xinhuai Wu; Scott B Reeder; Claude B Sirlin
Journal:  Radiology       Date:  2017-09-11       Impact factor: 11.105

4.  Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).

Authors:  Adrija Mamidipalli; Kathryn J Fowler; Gavin Hamilton; Tanya Wolfson; Yesenia Covarrubias; Calvin Tran; Soudabeh Fazeli; Curtis N Wiens; Alan McMillan; Nathan S Artz; Luke M Funk; Guilherme M Campos; Jacob A Greenberg; Anthony Gamst; Michael S Middleton; Jeffrey B Schwimmer; Scott B Reeder; Claude B Sirlin
Journal:  Eur Radiol       Date:  2020-04-21       Impact factor: 5.315

5.  Fetal Overnutrition and Adolescent Hepatic Fat Fraction: the Exploring Perinatal Outcomes in Children Study.

Authors:  Anna Bellatorre; Ann Scherzinger; Elizabeth Stamm; Mercedes Martinez; Brandy Ringham; Dana Dabelea
Journal:  J Pediatr       Date:  2017-10-16       Impact factor: 4.406

6.  Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.

Authors:  Jonathan C Hooker; Gavin Hamilton; Charlie C Park; Steven Liao; Tanya Wolfson; Soudabeh Fazeli Dehkordy; Cheng William Hong; Adrija Mamidipalli; Anthony Gamst; Rohit Loomba; Claude B Sirlin
Journal:  Abdom Radiol (NY)       Date:  2019-02

Review 7.  Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.

Authors:  Cyrielle Caussy; Scott B Reeder; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

8.  Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect.

Authors:  Stavra A Xanthakos; Andrew T Trout; Jonathan R Dillman
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 9.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

10.  MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.

Authors:  Cheng William Hong; Adrija Mamidipalli; Jonathan C Hooker; Gavin Hamilton; Tanya Wolfson; Dennis H Chen; Soudabeh Fazeli Dehkordy; Michael S Middleton; Scott B Reeder; Rohit Loomba; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2017-08-29       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.